English iCN Internal Distribution IPS Market Research Reportedtimes Research Newswire

Prostate Cancer Therapeutics Market To Garner Earnings Estimated At USD 16,557.08 Mn By 2026

prostate cancer therapeutics market to garner earnings estimated at usd 16557 08 mn by 2026

Oct 8, 2020 8:00 AM ET
iCrowd Newswire – Oct 8, 2020

With the presence of a large pool of participants, the global prostate cancer therapeutics market is displaying a highly competitive business landscape, finds a new research report by Zion Market Research (ZMR).

Current knowhow vis-à-vis the relevance of DNA damage repair mutations in patients having prostate cancer is predicted to create new growth frontiers for prostate cancer therapeutics business over the years to come. Moreover, the past decade has witnessed new breakthroughs in prostate cancer therapeutics including radium-233, enzalutamide, cabazitaxel, abiraterone acetate, and sipuleucel-T. In addition to this, the induction of new therapies such as immunotherapy, PARP inhibition, and radiopharmaceuticals can bring a paradigm shift in the prostate cancer therapeutics industry over the years ahead.

Get Access to the FREE sample report @ https://www.zionmarketresearch.com/sample/prostate-cancer-therapeutics-market 

Global Prostate Cancer Therapeutics Market

Furthermore, precision medicine utilizing the nutraceutical methodology is one of the major patterns used for developing the non-toxic therapeutics that can act synergistically with current anti-cancer agents in the countries like the U.S. Moreover, precision medicine helps in choosing of apt therapies for treating prostate cancer through proper genetic mapping. All these factors are likely to upsurge the expansion of the prostate cancer therapeutics market in the foreseeable future. Apart from this, breakthroughs in the oncology can result in early diagnosis of prostate cancer leading to on-time treatment of the disease. This will expand the scope of the business over the years to come.

Additionally, drug repositioning strategy has helped the firms in determining non-cancer medicines having anti-cancer properties along with tolerable side effects on the health of the patients. This aspect will further add to the market size over the forecast period.

Hospital Pharmacies Segment To Account For Major Market Share By 2026

Hospitals have remained the most preferred locations for admitting prostate cancer patients for the treatment. This has resulted in the huge popularity of the hospital pharmacies, thereby adding to its growth.

North America To Dominate The Overall Market Surge Over 2020-2026

Ongoing research programs, breakthroughs in the domain of biotechnology, and launching of vaccines like Sipuleucel-T have contributed massively towards the ascent of the prostate cancer therapeutics industry in North American sub-continent. The industry growth in the region is likely to persist even during the forecast timeline.

The key players involved in the prostate cancer therapeutics business are Bayer AG, Johnson & Johnson, Ipsen Group, Amgen, Inc., Endo Pharmaceuticals, Inc., AbbVie, Inc., Pfizer, Inc., AstraZeneca, Sanofi, and Sanpower Group.

The key players leveraging prostate cancer therapeutics market evolution and included in the report are:

  • Bayer AG
  • Johnson & Johnson
  • Ipsen Group
  • Amgen, Inc.
  • Endo Pharmaceuticals, Inc.
  • AbbVie, Inc.
  • Pfizer, Inc.
  • AstraZeneca
  • Sanofi
  • Sanpower Group

This report segments the Prostate Cancer Therapeutics market as follows:

Global Prostate Cancer Therapeutics Market: By Therapy Segment Analysis

  • Hormone Therapy
  • Targeted Therapy
  • Chemotherapy
  • Biologic Therapy

Global Prostate Cancer Therapeutics Market: By Distribution Channel Segment Analysis

  • Hospital Pharmacies
  • Online Sales
  • Retail Pharmacies
  • Others

Global Prostate Cancer Therapeutics Market: By Regional Segment Analysis

  • North America
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
  • Middle East and Africa

To view TOC of this report is available upon request @ https://www.zionmarketresearch.com/toc/prostate-cancer-therapeutics-market 

Contact Information:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com


iCrowdNewswire

Keywords:    Prostate Cancer Therapeutics Market

Add Comment

Click here to post a comment

Your email address will not be published. Required fields are marked *